LBD
ABMD

Landsberg Bennett & Dubbaneh’s Abiomed Inc ABMD Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,499
Closed -$251K – 247
2019
Q4 		$251K Buy
+1,499
New +$278K 0.06% 220
2019
Q3 		– Sell
-1,037
Closed -$275K – 223
2019
Q2 		$275K Buy
+1,037
New +$275K 0.07% 195

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's ABMD Position: Q1 2020 in Review

Landsberg Bennett & Dubbaneh sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 1,499 shares — an estimated $251K sold.

Landsberg Bennett & Dubbaneh first reported a position in ABMD in Q2 2019 and held it in 2 quarters. The position peaked at $275K in Q2 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Landsberg Bennett & Dubbaneh reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 1,499 Abiomed Inc shares in Q1 2020, an estimated $251K.
  • Landsberg Bennett & Dubbaneh first reported a position in Abiomed Inc in Q2 2019 and held it in 2 quarters.
  • Landsberg Bennett & Dubbaneh's Abiomed Inc position peaked at $275K in Q2 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q1 2020, filed 21 Apr 2020.